5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP

Haijun Chen, Tamara Tsalkova, Fang C. Mei, Yaohua Hu, Xiaodong Cheng, Jia Zhou

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Exchange proteins directly activated by cAMP (Epac) are a family of guanine nucleotide exchange factors that regulate a wide variety of intracellular processes in response to second messenger cAMP. To explore the structural determinants for Epac antagonist properties of high throughput screening (HTS) hit ESI-08, pyrimidine 1, a series of 5-cyano-6-oxo-1,6-dihydro-pyrimidine analogues have been synthesized and evaluated for their activities for Epac inhibition. Structure-activity relationship (SAR) analysis led to the identification of three more potent Epac antagonists (6b, 6g, and 6h). These inhibitors may serve as valuable pharmacological probes for further elucidation of the physiological functions and mechanisms of Epac regulation. Our SAR results and molecular docking studies have also revealed that further optimization of the moieties at the C-6 position of pyrimidine scaffold may allow us to discover more potent Epac-specific antagonists.

Original languageEnglish (US)
Pages (from-to)4038-4043
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume22
Issue number12
DOIs
StatePublished - Jun 15 2012

Fingerprint

Pyrimidines
Protein Transport
Proteins
Structure-Activity Relationship
Guanine Nucleotide Exchange Factors
Second Messenger Systems
Scaffolds
Screening
Throughput
Pharmacology
pyrimidine

Keywords

  • Antagonists
  • Exchange proteins directly activated by cAMP (Epac)
  • Pyrimidine analogues
  • Structure-activity relationship (SAR)

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP. / Chen, Haijun; Tsalkova, Tamara; Mei, Fang C.; Hu, Yaohua; Cheng, Xiaodong; Zhou, Jia.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 22, No. 12, 15.06.2012, p. 4038-4043.

Research output: Contribution to journalArticle

Chen, Haijun ; Tsalkova, Tamara ; Mei, Fang C. ; Hu, Yaohua ; Cheng, Xiaodong ; Zhou, Jia. / 5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP. In: Bioorganic and Medicinal Chemistry Letters. 2012 ; Vol. 22, No. 12. pp. 4038-4043.
@article{ab6b94ea6e0b41a58d7d31bdf5abc2b5,
title = "5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP",
abstract = "Exchange proteins directly activated by cAMP (Epac) are a family of guanine nucleotide exchange factors that regulate a wide variety of intracellular processes in response to second messenger cAMP. To explore the structural determinants for Epac antagonist properties of high throughput screening (HTS) hit ESI-08, pyrimidine 1, a series of 5-cyano-6-oxo-1,6-dihydro-pyrimidine analogues have been synthesized and evaluated for their activities for Epac inhibition. Structure-activity relationship (SAR) analysis led to the identification of three more potent Epac antagonists (6b, 6g, and 6h). These inhibitors may serve as valuable pharmacological probes for further elucidation of the physiological functions and mechanisms of Epac regulation. Our SAR results and molecular docking studies have also revealed that further optimization of the moieties at the C-6 position of pyrimidine scaffold may allow us to discover more potent Epac-specific antagonists.",
keywords = "Antagonists, Exchange proteins directly activated by cAMP (Epac), Pyrimidine analogues, Structure-activity relationship (SAR)",
author = "Haijun Chen and Tamara Tsalkova and Mei, {Fang C.} and Yaohua Hu and Xiaodong Cheng and Jia Zhou",
year = "2012",
month = "6",
day = "15",
doi = "10.1016/j.bmcl.2012.04.082",
language = "English (US)",
volume = "22",
pages = "4038--4043",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "12",

}

TY - JOUR

T1 - 5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP

AU - Chen, Haijun

AU - Tsalkova, Tamara

AU - Mei, Fang C.

AU - Hu, Yaohua

AU - Cheng, Xiaodong

AU - Zhou, Jia

PY - 2012/6/15

Y1 - 2012/6/15

N2 - Exchange proteins directly activated by cAMP (Epac) are a family of guanine nucleotide exchange factors that regulate a wide variety of intracellular processes in response to second messenger cAMP. To explore the structural determinants for Epac antagonist properties of high throughput screening (HTS) hit ESI-08, pyrimidine 1, a series of 5-cyano-6-oxo-1,6-dihydro-pyrimidine analogues have been synthesized and evaluated for their activities for Epac inhibition. Structure-activity relationship (SAR) analysis led to the identification of three more potent Epac antagonists (6b, 6g, and 6h). These inhibitors may serve as valuable pharmacological probes for further elucidation of the physiological functions and mechanisms of Epac regulation. Our SAR results and molecular docking studies have also revealed that further optimization of the moieties at the C-6 position of pyrimidine scaffold may allow us to discover more potent Epac-specific antagonists.

AB - Exchange proteins directly activated by cAMP (Epac) are a family of guanine nucleotide exchange factors that regulate a wide variety of intracellular processes in response to second messenger cAMP. To explore the structural determinants for Epac antagonist properties of high throughput screening (HTS) hit ESI-08, pyrimidine 1, a series of 5-cyano-6-oxo-1,6-dihydro-pyrimidine analogues have been synthesized and evaluated for their activities for Epac inhibition. Structure-activity relationship (SAR) analysis led to the identification of three more potent Epac antagonists (6b, 6g, and 6h). These inhibitors may serve as valuable pharmacological probes for further elucidation of the physiological functions and mechanisms of Epac regulation. Our SAR results and molecular docking studies have also revealed that further optimization of the moieties at the C-6 position of pyrimidine scaffold may allow us to discover more potent Epac-specific antagonists.

KW - Antagonists

KW - Exchange proteins directly activated by cAMP (Epac)

KW - Pyrimidine analogues

KW - Structure-activity relationship (SAR)

UR - http://www.scopus.com/inward/record.url?scp=84861573952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861573952&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2012.04.082

DO - 10.1016/j.bmcl.2012.04.082

M3 - Article

VL - 22

SP - 4038

EP - 4043

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 12

ER -